Identification
Personal identification
- Full name
- Catarina Isabel de Sousa Lopes
Citation names
- Lopes, Catarina S.
Author identifiers
- Ciência ID
- 681C-5ABC-3934
- ORCID iD
- 0000-0001-8561-4527
- Scopus Author Id
- 57204046775
Addresses
- GIMM - Gulbenkian Institute for Molecular Medicine, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal, 1649-028, Lisboa, Lisboa, Portugal (Professional)
Knowledge fields
- Natural sciences - Biological Sciences - Biophysics
- Natural sciences - Biological Sciences - Biochemical Research Methods
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese (Mother tongue) | |||||
English | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) | Intermediate (B1) | Upper intermediate (B2) |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2024/10/01 - Current | Postdoc (Research) | Gulbenkian Institute for Molecular Medicine, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2021/03/29 - 2024/03/28 | Fibrinogen-erythrocyte interaction as a new approach on the early detection of thrombotic events in vascular diseases
PTDC/EMD-TLM/7289/2020
Research Fellow
Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021/07/01 - 2022/04/30 | Using AFM to study erythrocytes biophysical properties on cardiovascular diseases and amyotrophic lateral sclerosis
COVID/BD/151823/2021
PhD Student Fellow
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2017/05/01 - 2021/05/01 | Using AFM to study erythrocyte biophysical properties changes on cardiovascular diseases and amyotrophic lateral sclerosis
PD/BD/135045/2017
PhD Student Fellow
Instituto de Medicina Molecular, Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
Contract
Designation | Funders | |
---|---|---|
2019/01/01 - 2019/12/31 | Instituto de Medicina Molecular
UID/BIM/50005/2019
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Other
Designation | Funders | |
---|---|---|
2024/10/01 - Current | Synthetic blood cells as an alternative to blood products
Post-doc
|
Horizon Europe |
2024/01/01 - 2024/12/31 | ImPlat: A single-cell platform to validate material scaffolds and drugs for the enhanced osteointegration of biomedical implants
Project#11 IMPLAT
Researcher
|
Ongoing
|
Outputs
Publications
Book chapter |
|
Conference poster |
|
Journal article |
|
Activities
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2024/02/15 - 2024/02/16 | Workshop of Dynamic Cell Culture with Microfluidics - from unicellular to complex systems
Workshop
|
Dynamic Cell Culture with Microfluidics - from unicellular to complex systems
Instituto Gulbenkian de Ciência, Portugal
|
Interview (newspaper / magazine)
Activity description | Newspaper / Forum | |
---|---|---|
2024/10/15 | Cientistas de Coimbra realizam estudo para deteção precoce de eventos trombóticos Cientistas da Universidade de Coimbra criaram simulações para modelar a deformação dos glóbulos vermelhos. Pretendem estudar o efeito do fibrinogénio na viscosidade do sangue e na adesão celular. No âmbito do projeto, liderado pelo Instituto de Medicina Molecular (iMM), “os especialistas estão a estudar o aumento da viscosidade sanguínea, frequentemente associado a níveis elevados da proteína fibrinogénio”. | Observador |
2024/05/03 | Cardiologia. Detetar riscos para prevenir com cirurgias e não ter de remediar com internamento. E evitar mortes | Observador |